RESUMO
We report on a female patient presenting with primary progressive aphasia (PPA) and her brother presenting with psychosis. Both siblings had an R5H-mutation in exon 1 of the MAPT-gene. The PPA patient presented for the first time at the age of 72 years with a 4-year-history of language impairment. After a progressive course the patient died at the age of 76 years. The R5H-MAPT-gene mutation detected in the siblings has been described only once in 2002 by Hayashi et al. [1]. In this previous case from Japan, a 75-year-old patient initially displayed amnesia and disorientation. He became bedridden, with progressive mutism and rigidity of the upper extremities. Noteworthy are the manifold signs and symptoms in R5H-mutations and the late age of onset. For future trials, the detection of biomarkers for frontotemporal lobar degeneration in presymptomatic cohorts like the genetic frontotemporal dementia initiative (GENFI) is of help for stratifying subjects at risk.
Assuntos
Afasia Primária Progressiva/genética , Proteínas tau/genética , Idade de Início , Idoso , Afasia Primária Progressiva/diagnóstico , Afasia Primária Progressiva/psicologia , Progressão da Doença , Feminino , Demência Frontotemporal/genética , Humanos , Imageamento por Ressonância Magnética , Masculino , Mutação/genética , Tomografia por Emissão de Pósitrons , Transtornos Psicóticos/genéticaRESUMO
Progressive aphasia (PA) caused by neurodegenerative diseases is much less prevalent than aphasia following vascular brain lesions. Clinically, the progressive aphasias can be divided in progressive non-fluent aphasia, semantic dementia and logopenic aphasia. Differential diagnosis is based on a detailed language assessment and neuroimaging. Compared with the therapy of aphasia following stroke the treatment of patients with PA has been neglected. However, recently potential therapeutic options have been evaluated regarding feasibility and efficacy.